Bromadoline

Bromadoline
Clinical data
Other names	Bromadoline
ATC code	none;
Identifiers
	IUPAC name 4-bromo-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]benzamide;
CAS Number	; 2418521-61-4; 67579-24-2 (mixture of trans isomers);
PubChem CID	6328449;
ChemSpider	4886584 ;
UNII	R8DWN01P1M;
CompTox Dashboard (EPA)	DTXSID40217897 ;
Chemical and physical data
Formula	C15H21BrN2O
Molar mass	325.250 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN(C)[C@@H]1CCCC[C@H]1NC(=O)C2=CC=C(C=C2)Br;
	InChI InChI=1S/C15H21BrN2O/c1-18(2)14-6-4-3-5-13(14)17-15(19)11-7-9-12(16)10-8-11/h7-10,13-14H,3-6H2,1-2H3,(H,17,19)/t13-,14-/m1/s1; Key:UFDJFJYMMIZKLG-ZIAGYGMSSA-N;
	(verify)

Bromadoline (U-47931E)^[1] is an opioid analgesic selective for the μ-opioid receptor^[2] developed by the Upjohn company in the 1970s.^[3] The drug has a potency lying between that of codeine and morphine, being slightly stronger than pentazocine.^[4] Bromadoline is related to AH-7921 and U-47700.^[5]